<DOC>
	<DOCNO>NCT00720161</DOCNO>
	<brief_summary>Obesity insulin resistance paediatric population provide increase challenge . Children neurological neuromuscular disease even prone obesity : locomotor impairment lead increasingly sedentary lifestyle , decrease physical fitness increase body fat ( 1-3 ) . Obesity , turn , associate decrease physical fitness increase body fat . In study want evaluate effect insulin-sensitizer , metformin , group overweight/obese patient neurological neuromuscular disease . Metformin well-established insulin sensitizer .</brief_summary>
	<brief_title>Metformin Children With Motor Deficit</brief_title>
	<detailed_description />
	<mesh_term>Neuromuscular Diseases</mesh_term>
	<mesh_term>Spinal Dysraphism</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Patients neurogenic myogenic motor deficit , clinically obese excessively gain weight last year . Exclusion criterion know type 1 type 2 diabetes mellitus contraindication metformin therapy .</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>metformin , spina bifida , duchenne , insulin resistance</keyword>
</DOC>